These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8932822)

  • 1. Health status of long term survivors after myeloablative therapy and bone marrow transplantation in children.
    Manfredini L; Garaventa A; Barra S; De Caro E; Picco P; Faraci M; De Marco R; Stura M; Calcagno E; Gianiorio P; Zarri D; Garrè ML; Dallorso S; Lanino E; Massimo L; Dini G
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():163-4. PubMed ID: 8932822
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of bone marrow transplantation on dental status in children with leukaemia.
    Uderzo C; Fraschini D; Balduzzi A; Galimberti S; Arrigo C; Biagi E; Pignanelli M; Nicolini B; Rovelli A
    Bone Marrow Transplant; 1997 Nov; 20(10):865-9. PubMed ID: 9404928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
    O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
    Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant?
    Shaw PJ; Bleakley M; Lau L
    Bone Marrow Transplant; 2004 Aug; 34(3):275-6. PubMed ID: 15156168
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
    Slatter MA; Gennery AR; Cheetham TD; Bhattacharya A; Crooks BN; Flood TJ; Cant AJ; Abinun M
    Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation.
    Cohen A; Duell T; Socié G; van Lint MT; Weiss M; Tichelli A; Rovelli A; Apperley JF; Ljungman P; Kolb HJ
    Bone Marrow Transplant; 1999 May; 23(10):1043-7. PubMed ID: 10373071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Berger C; Le-Gallo B; Donadieu J; Richard O; Devergie A; Galambrun C; Bordigoni P; Vilmer E; Plouvier E; Perel Y; Michel G; Stephan JL
    Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
    Talano JM; Casper JT; Camitta BM; Keever-Taylor CA; Murray KJ; Eapen M; Pierce KL; Margolis DA
    Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
    Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental manifestations in severe combined immunodeficiency following bone marrow transplantation.
    Cole BO; Welbury RR; Bond E; Abinun M
    Bone Marrow Transplant; 2000 May; 25(9):1007-9. PubMed ID: 10800072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects in long-term survivors after treatment for childhood acute leukemia.
    Haddy TB; Mosher RB; Reaman GH
    Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients.
    Bertrand Y; Müller SM; Casanova JL; Morgan G; Fischer A; Friedrich W
    Bone Marrow Transplant; 2002 May; 29(9):759-62. PubMed ID: 12040473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
    Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
    Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor.
    Tanaka T; Ishida H; Shirakawa H; Amano H; Nishida H; Tanabe K
    Int J Urol; 2007 Nov; 14(11):1044-5. PubMed ID: 17956534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
    Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.